CRAIG FEASTER: Open Payments
NPI 1912905795 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 92 payments from 12 companies in 2025. Trend: 2023 $4,349 · 2024 $1,016 · 2025 $1,455
Food & beverage: $1,455
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 27 | $297 |
| E.R. Squibb & Sons, L.L.C. | 15 | $212 |
| Janssen Pharmaceuticals, Inc | 8 | $197 |
| Otsuka America Pharmaceutical, Inc. | 10 | $194 |
| Alkermes, Inc. | 10 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $166 |
| Collegium Pharmaceutical, Inc. | 5 | $101 |
| ABBVIE INC. | 2 | $45 |
| Lundbeck LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: Qelbree, COBENFY, CAPLYTA, SPRAVATO, LYBALVI, REXULTI, Jornay PM, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
